Followers | 1196 |
Posts | 9766 |
Boards Moderated | 0 |
Alias Born | 03/30/2010 |
Wednesday, May 11, 2016 8:48:12 AM
http://www.otcmarkets.com/stock/CHZP/news
TORONTO, ON -- (Marketwired) -- 05/03/16 -- Chess Supersite Corporation (OTC PINK: CHZP) has signed an Agreement with ACP (Association of Chess Professionals http://www.chessprofessionals.org) to become the Title Sponsor of the ACP Women's Cup 2016, which will be officially promoted as ACP Chess Supersite Women's Cup 2016. Chess Supersite Corp. will receive exclusive rights for the live video broadcast for the event. ACP will be in charge of organizing the event at the highest level, contracting top women chess players and ensuring a professional video broadcast with the live commentaries of the invited experts -- all which is in line with the standards set by the ACP in its previous events. This event will last at least four days. ACP will promote the partnership with Chess Supersite Corp. immediately. For the first time for the tournaments of this calibre, the time control will deploy DELAYS instead of INCREMENTS. The significance of this is that for the first time ever in the Grandmasters' Tournament our members will enjoy participation in the "CHOOSE YOUR MOVE AND WIN" contests and be eligible for the monthly Grand Prizes as well as for Prizes in each game.
ACP (Association of Chess Professionals) is a not-for-profit organization, whose main purpose is the protection of chess professionals' rights and the practice and promotion of chess worldwide, in particular through the organization of chess tournaments and other chess events. ACP has united over 1000 chess professionals from 84 countries and the number is constantly increasing. Since registration, the ACP has organized more than a dozen tournaments with a total budget in excess of 2 million Euro.
Recent CBDY News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 10:04:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:12:49 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/04/2023 09:30:29 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM